Home Cart 0 Sign in  

[ CAS No. 1027757-13-6 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1027757-13-6
Chemical Structure| 1027757-13-6
Structure of 1027757-13-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 1027757-13-6 ]

Related Doc. of [ 1027757-13-6 ]

Alternatived Products of [ 1027757-13-6 ]

Product Details of [ 1027757-13-6 ]

CAS No. :1027757-13-6 MDL No. :MFCD03001334
Formula : C19H23BO3 Boiling Point : -
Linear Structure Formula :- InChI Key :OYMQYMSYMNEKLI-UHFFFAOYSA-N
M.W :310.20 Pubchem ID :3525007
Synonyms :

Calculated chemistry of [ 1027757-13-6 ]

Physicochemical Properties

Num. heavy atoms : 23
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.37
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 93.9
TPSA : 27.69 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.09 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 4.37
Log Po/w (WLOGP) : 3.41
Log Po/w (MLOGP) : 2.63
Log Po/w (SILICOS-IT) : 3.36
Consensus Log Po/w : 2.75

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.64
Solubility : 0.00713 mg/ml ; 0.000023 mol/l
Class : Moderately soluble
Log S (Ali) : -4.67
Solubility : 0.00667 mg/ml ; 0.0000215 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -6.64
Solubility : 0.0000706 mg/ml ; 0.000000228 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.31

Safety of [ 1027757-13-6 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1027757-13-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1027757-13-6 ]

[ 1027757-13-6 ] Synthesis Path-Downstream   1~6

  • 1
  • [ 1027757-13-6 ]
  • [ 127413-58-5 ]
  • [ 1190387-34-8 ]
YieldReaction ConditionsOperation in experiment
23% With tetrakis(triphenylphosphine) palladium(0); potassium carbonate In toluene at 80℃;
  • 2
  • [ 1027757-13-6 ]
  • [ 27126-76-7 ]
  • [ 1417417-98-1 ]
YieldReaction ConditionsOperation in experiment
98% With trifluoroacetic acid at 20℃; for 3h;
  • 3
  • [ 1027757-13-6 ]
  • [ 1610520-84-7 ]
  • [ 1610518-87-0 ]
YieldReaction ConditionsOperation in experiment
46% With [1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene](3-chloropyridyl)palladium(ll) dichloride; potassium carbonate In isopropyl alcohol at 110℃; for 0.5h; Microwave irradiation; 71 Example 71 : 7-(2-(benzyloxy)phenyl)-5-methyl-2-((4-(methylsulphonyl)piperazin-1- yl)methyl)thienor3,2-clpyridin-4(5H)-one To a solution of 7-bromo-5-methyl-2-((4-(methylsulphonyl)piperazin-1-yl)methyl)thieno[3,2-c]pyridin- 4(5H)-one (for a preparation see Intermediate 69, 150 mg, 0.357 mmol) and 2-(2- (benzyloxy)phenyl)-4, 4, 5, 5-tetra methyl- 1 ,3,2-dioxaborolane (166 mg, 0.535 mmol) in isopropanol (5 ml.) were successively added potassium carbonate (0.892 ml_, 1.784 mmol) and PEPPSI (24.25 mg, 0.036 mmol). The resulting mixture was heated at 1 10 °C in the microwave for 30 min, whereupon the reaction mixture was allowed to cool down to rt and was concentrated in vacuo. The crude residue was partitioned between EtOAc and a saturated aqueous solution of sodium bicarbonate. The phases were separated, the aqueous phase was extracted 3 times with EtOAc and the combined organic layers were washed with brine, dried over MgSC , filtered and concentrated in vacuo. The residue was purified via MDAP. The appropriate fractions were combined and concentrated in vacuo to give 7-(2-(benzyloxy)phenyl)-5-methyl-2-((4-(methylsulphonyl)piperazin-1- yl)methyl)thieno[3,2-c]pyridin-4(5H)-one (85 mg, 46% yield) as a white solid. LCMS (2 min, Formic Acid): Rt = 0.89 min, MH+ = 524.
  • 4
  • [ 20012-63-9 ]
  • [ 1027757-13-6 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1.1: formic acid; sodium cyanoborohydride / methanol / 16 h / 0 - 20 °C / pH 3 - 4 / Inert atmosphere 1.2: 0 °C / Inert atmosphere 2.1: bis(1,5-cyclooctadiene)nickel(0); 1,3-dicyclohexyl-1H-imidazol-3-ium chloride; potassium <i>tert</i>-butylate / toluene; 2-ethoxy-ethanol / 24 h / 50 °C / Schlenk technique; Inert atmosphere
  • 5
  • 2-(benzyloxy)-N,N,N-trimethylbenzenaminium trifluoromethanesulfonate [ No CAS ]
  • [ 73183-34-3 ]
  • [ 1027757-13-6 ]
YieldReaction ConditionsOperation in experiment
55% With bis(1,5-cyclooctadiene)nickel(0); potassium <i>tert</i>-butylate; 1,3-dicyclohexyl-1H-imidazol-3-ium chloride In 2-ethoxy-ethanol; toluene at 50℃; for 24h; Schlenk technique; Inert atmosphere;
  • 6
  • [ 1027757-13-6 ]
  • [ 1589518-11-5 ]
  • C35H27O2P [ No CAS ]
  • C35H27O2P [ No CAS ]
YieldReaction ConditionsOperation in experiment
With C26H30FeNP; palladium diacetate; sodium phosphate In 1,4-dioxane at 40 - 100℃; for 100h; Inert atmosphere; Overall yield = 80 %; Optical yield = 86 %ee; 12 Example 12: Preparation of Compound 12 Under nitrogen protection,(0.25 mmol) of (1-bromo-2-naphthyl) -diphenylphosphine oxide,62 mg (0.5 mmol) of aryl boronate,159 mg (0.75 mmol) of Na3PO4,5.65 mg (0.012 mmol) of ligand L4,4.58 mg (0.005 mmol) of Pd (OAc) 2 was added to the reaction tube.3 mL of oxygen-free dioxane as solvent,40-100 ° C for 100 hours.The reaction system is filtered to remove insoluble matter, concentrated, and the crude product is separated and purified by a silica gel column to obtain a pale yellow solid product. Ml, tR = 7.69 min, HPLC: m / z: 80%, enantioselectivity: 86% ee (high performance liquid chromatography, ChiralcelAD-H column, 25C, n-hexane: isopropanol = 75:25, 1.0 mL / 12.20 min)
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1027757-13-6 ]

Organoboron

Chemical Structure| 1204580-85-7

[ 1204580-85-7 ]

2-(2-(Benzyloxy)-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.99

Chemical Structure| 1626407-70-2

[ 1626407-70-2 ]

2-(4-(Benzyloxy)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.99

Chemical Structure| 1626407-70-2

[ 1626407-70-2 ]

2-(4-(Benzyloxy)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.99

Chemical Structure| 1059066-01-1

[ 1059066-01-1 ]

2-{4-[(4-Methoxyphenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.95

Chemical Structure| 754226-40-9

[ 754226-40-9 ]

2-(4-(Benzyloxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.95

Aryls

Chemical Structure| 1204580-85-7

[ 1204580-85-7 ]

2-(2-(Benzyloxy)-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.99

Chemical Structure| 1626407-70-2

[ 1626407-70-2 ]

2-(4-(Benzyloxy)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.99

Chemical Structure| 1059066-01-1

[ 1059066-01-1 ]

2-{4-[(4-Methoxyphenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.95

Chemical Structure| 754226-40-9

[ 754226-40-9 ]

2-(4-(Benzyloxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.95

Ethers

Chemical Structure| 1204580-85-7

[ 1204580-85-7 ]

2-(2-(Benzyloxy)-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.99

Chemical Structure| 1626407-70-2

[ 1626407-70-2 ]

2-(4-(Benzyloxy)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.99

Chemical Structure| 1059066-01-1

[ 1059066-01-1 ]

2-{4-[(4-Methoxyphenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.95

Chemical Structure| 754226-40-9

[ 754226-40-9 ]

2-(4-(Benzyloxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.95

Esters

Chemical Structure| 1204580-85-7

[ 1204580-85-7 ]

2-(2-(Benzyloxy)-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.99

Chemical Structure| 2121511-63-3

[ 2121511-63-3 ]

2-(2-(Benzyloxy)-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.99

Chemical Structure| 1626407-70-2

[ 1626407-70-2 ]

2-(4-(Benzyloxy)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.99

Chemical Structure| 2121514-58-5

[ 2121514-58-5 ]

2-(2-(Benzyloxy)-4,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.97

Chemical Structure| 2121514-22-3

[ 2121514-22-3 ]

2-(3-(Benzyloxy)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.96